|
1
|
American College of Emergency Physicians;
Society for Cardiovascular Angiography and Interventions, ; O'Gara
PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA,
Ettinger SM, Fang JC, et al: American College of Cardiology
Foundation/American Heart Association Task Force on Practice
Guidelines: 2013 ACCF/AHA guideline for the management of
ST-elevation myocardial infarction: A report of the American
college of cardiology foundation/American heart association task
force on practice guidelines. J Am Coll Cardiol. 61:e78–e140.
2013.PubMed/NCBI
|
|
2
|
de Waha S, Eitel I, Desch S, Fuernau G,
Pöss J, Schuler G and Thiele H: Impact of multivessel coronary
artery disease on reperfusion success in patients with ST-elevation
myocardial infarction-insights from cardiac magnetic resonance
imaging. J Cardiovasc Magn Reson. Dec 21–2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Toma M, Buller CE, Westerhout CM, Fu Y,
O'Neill WW, Holmes DR Jr, Hamm CW, Granger CB and Armstrong PW:
APEX-AMI Investigators: Non-culprit coronary artery percutaneous
coronary intervention during acute ST-segment elevation myocardial
infarction: Insights from the APEX-AMI trial. Eur Heart J.
31:1701–1707. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jaski BE, Cohen JD, Trausch J, Marsh DG,
Bail GR, Overlie PA, Skowronski EW and Smith SC Jr: Outcome of
urgent percutaneous transluminal coronary angioplasty in acute
myocardial infarction: Comparison of single-vessel versus
multivessel coronary artery disease. Am Heart J. 124:1427–1433.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sorajja P, Gersh BJ, Cox DA, McLaughlin
MG, Zimetbaum P, Costantini C, Stuckey T, Tcheng JE, Mehran R,
Lansky AJ, et al: Impact of multivessel disease on reperfusion
success and clinical outcomes in patients undergoing primary
percutaneous coronary intervention for acute myocardial infarction.
Eur Heart J. 28:1709–1716. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
King SB III, Smith SC Jr, Hirshfeld JW Jr,
Jacobs AK, Morrison DA, Williams DO; 2005 WRITING COMMITTEE
MEMBERS, ; Feldman TE, Kern MJ, O'Neill WW, et al: 2007 Focused
update of the ACC/AHA/SCAI 2005 guideline update for percutaneous
coronary intervention: A report of the American college of
cardiology/American heart association task force on practice
guidelines: 2007 Writing group to review new evidence and update
the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary
intervention, writing on behalf of the 2005 writing committee.
Circulation. 117:261–295. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qarawani D, Nahir M, Abboud M, Hazanov Y
and Hasin Y: Culprit only versus complete coronary
revascularization during primary PCI. Int J Cardiol. 123:288–292.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yusuf S, Mehta SR, Chrolavicius S, Afzal
R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin
L, et al: OASIS-6 Trial Group: Effects of fondaparinux on mortality
and reinfarction in patients with acute ST-segment elevation
myocardial infarction: The OASIS-6 randomized trial. JAMA.
295:1519–1530. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sabatine MS, Cannon CP, Gibson CM,
López-Sendón JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill
KA, Skene AM, et al: CLARITY-TIMI 28 Investigators: Addition of
clopidogrel to aspirin and fibrinolytic therapy for myocardial
infarction with ST-segment elevation. N Engl J Med. 352:1179–1189.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wald DS, Morris JK, Wald NJ, Chase AJ,
Edwards RJ, Hughes LO, Berry C and Oldroyd KG: PRAMI Investigators:
Randomized trial of preventive angioplasty in myocardial
infarction. N Engl J Med. 369:1115–1123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gershlick AH, Khan JN, Kelly DJ, Greenwood
JP, Sasikaran T, Curzen N, Blackman DJ, Dalby M, Fairbrother KL,
Banya W, et al: Randomized trial of complete versus lesion-only
revascularization in patients undergoing primary percutaneous
coronary intervention for STEMI and multivessel disease: The
CvLPRIT trial. J Am Coll Cardiol. 65:963–972. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stone GW, Witzenbichler B, Guagliumi G,
Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ,
Pocock SJ, et al: HORIZONS-AMI Trial Investigators: Bivalirudin
during primary PCI in acute myocardial infarction. N Engl J Med.
358:2218–2230. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stone GW, Lansky AJ, Pocock SJ, Gersh BJ,
Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie
BR, et al: HORIZONS-AMI Trial Investigators: Paclitaxel-eluting
stents versus bare-metal stents in acute myocardial infarction. N
Engl J Med. 360:1946–1959. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mehran R, Lansky AJ, Witzenbichler B,
Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann
F, Gersh BJ, et al: HORIZONS-AMI Trial Investigators: Bivalirudin
in patients undergoing primary angioplasty for acute myocardial
infarction (HORIZONS-AMI): 1-year results of a randomised
controlled trial. Lancet. 374:1149–1159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Paulus WJ, Tschöpe C, Sanderson JE,
Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De
Keulenaer G, Leite-Moreira AF, et al: How to diagnose diastolic
heart failure: A consensus statement on the diagnosis of heart
failure with normal left ventricular ejection fraction by the heart
failure and echocardiography associations of the european society
of cardiology. Eur Heart J. 28:2539–2550. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cutlip DE, Windecker S, Mehran R, Boam A,
Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, et al:
Academic Research Consortium: Clinical end points in coronary stent
trials: A case for standardized definitions. Circulation.
115:2344–2351. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Di Mario C, Mara S, Flavio A, Imad S,
Antonio M, Anna P, Emanuela P, Stefano DS, Angelo R, Stefania C, et
al: Single vs multivessel treatment during primary angioplasty:
Results of the multicentre randomised HEpacoat™ for cuLPrit or
multivessel stenting for acute myocardial infarction (HELP AMI)
Study. Int J Cardiovas Interve. 6:128–133. 2004. View Article : Google Scholar
|
|
18
|
Hochman JS, Sleeper LA, Webb JG, Dzavik V,
Buller CE, Aylward P, Col J and White HD: SHOCK Investigators:
Early revascularization and long-term survival in cardiogenic shock
complicating acute myocardial infarction. JAMA. 295:2511–2515.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vlaar PJ, Mahmoud KD, Holmes DR Jr, van
Valkenhoef G, Hillege HL, van der Horst IC, Zijlstra F and de Smet
BJ: Culprit vessel only versus multivessel and staged percutaneous
coronary intervention for multivessel disease in patients
presenting with ST-segment elevation myocardial infarctiona
pairwise and network meta-analysis. J Am Coll Cardiol. 58:692–703.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bainey KR, Mehta SR, Lai T and Welsh RC:
Complete vs culprit-only revascularization for patients with
multivessel disease undergoing primary percutaneous coronary
intervention for ST-segment elevation myocardial infarction: A
systematic review and meta-analysis. Am Heart J. 167:1.e12–14.e12.
2014. View Article : Google Scholar
|
|
21
|
Sethi A, Bahekar A, Bhuriya R, Singh S,
Ahmed A and Khosla S: Complete versus culprit only
revascularization in acute ST elevation myocardial infarction: A
meta-analysis. Catheter Cardiovasc Interv. 77:163–170. 2011.
View Article : Google Scholar : PubMed/NCBI
|
